These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 33483253)

  • 1. Derangement of hepatic polyamine, folate, and methionine cycle metabolism in cystathionine beta-synthase-deficient homocystinuria in the presence and absence of treatment: Possible implications for pathogenesis.
    Maclean KN; Jiang H; Phinney WN; Mclagan BM; Roede JR; Stabler SP
    Mol Genet Metab; 2021 Feb; 132(2):128-138. PubMed ID: 33483253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulation of hepatic one-carbon metabolism in classical homocystinuria: Implications of redox-sensitive DHFR repression and tetrahydrofolate depletion for pathogenesis and treatment.
    Maclean KN; Jiang H; Neill PD; Chanin RR; Hurt KJ; Orlicky DJ; Bottiglieri T; Roede JR; Stabler SP
    FASEB J; 2024 Jul; 38(13):e23795. PubMed ID: 38984928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Taurine alleviates repression of betaine-homocysteine
    Maclean KN; Jiang H; Phinney WN; Keating AK; Hurt KJ; Stabler SP
    FASEB J; 2019 May; 33(5):6339-6353. PubMed ID: 30768359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term betaine therapy in a murine model of cystathionine beta-synthase deficient homocystinuria: decreased efficacy over time reveals a significant threshold effect between elevated homocysteine and thrombotic risk.
    Maclean KN; Jiang H; Greiner LS; Allen RH; Stabler SP
    Mol Genet Metab; 2012 Mar; 105(3):395-403. PubMed ID: 22192524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Taurine treatment prevents derangement of the hepatic γ-glutamyl cycle and methylglyoxal metabolism in a mouse model of classical homocystinuria: regulatory crosstalk between thiol and sulfinic acid metabolism.
    Maclean KN; Jiang H; Aivazidis S; Kim E; Shearn CT; Harris PS; Petersen DR; Allen RH; Stabler SP; Roede JR
    FASEB J; 2018 Mar; 32(3):1265-1280. PubMed ID: 29101223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered hepatic sulfur metabolism in cystathionine β-synthase-deficient homocystinuria: regulatory role of taurine on competing cysteine oxidation pathways.
    Jiang H; Stabler SP; Allen RH; Abman SH; Maclean KN
    FASEB J; 2014 Sep; 28(9):4044-54. PubMed ID: 24891521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulfur amino acid metabolism in Zucker diabetic fatty rats.
    Kwak HC; Kim YM; Oh SJ; Kim SK
    Biochem Pharmacol; 2015 Aug; 96(3):256-66. PubMed ID: 26047850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma homocysteine level and hepatic sulfur amino acid metabolism in mice fed a high-fat diet.
    Yun KU; Ryu CS; Oh JM; Kim CH; Lee KS; Lee CH; Lee HS; Kim BH; Kim SK
    Eur J Nutr; 2013 Feb; 52(1):127-34. PubMed ID: 22209966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered expression of apoA-I, apoA-IV and PON-1 activity in CBS deficient homocystinuria in the presence and absence of treatment: possible implications for cardiovascular outcomes.
    Jiang H; Stabler SP; Allen RH; Maclean KN
    Mol Genet Metab; 2012 Sep; 107(1-2):55-65. PubMed ID: 22633282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutive induction of pro-inflammatory and chemotactic cytokines in cystathionine beta-synthase deficient homocystinuria.
    Keating AK; Freehauf C; Jiang H; Brodsky GL; Stabler SP; Allen RH; Graham DK; Thomas JA; Van Hove JL; Maclean KN
    Mol Genet Metab; 2011 Aug; 103(4):330-7. PubMed ID: 21601502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interplay of Enzyme Therapy and Dietary Management of Murine Homocystinuria.
    Park I; Bublil EM; Glavin F; Majtan T
    Nutrients; 2020 Sep; 12(9):. PubMed ID: 32971905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cystathionine beta-synthase deficiency alters hepatic phospholipid and choline metabolism: Post-translational repression of phosphatidylethanolamine N-methyltransferase is a consequence rather than a cause of liver injury in homocystinuria.
    Jacobs RL; Jiang H; Kennelly JP; Orlicky DJ; Allen RH; Stabler SP; Maclean KN
    Mol Genet Metab; 2017 Apr; 120(4):325-336. PubMed ID: 28291718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavior, body composition, and vascular phenotype of homocystinuric mice on methionine-restricted diet or enzyme replacement therapy.
    Majtan T; Park I; Cox A; Branchford BR; di Paola J; Bublil EM; Kraus JP
    FASEB J; 2019 Nov; 33(11):12477-12486. PubMed ID: 31450979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysregulated Hepatic Methionine Metabolism Drives Homocysteine Elevation in Diet-Induced Nonalcoholic Fatty Liver Disease.
    Pacana T; Cazanave S; Verdianelli A; Patel V; Min HK; Mirshahi F; Quinlivan E; Sanyal AJ
    PLoS One; 2015; 10(8):e0136822. PubMed ID: 26322888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deciphering pathophysiological mechanisms underlying cystathionine beta-synthase-deficient homocystinuria using targeted metabolomics, liver proteomics, sphingolipidomics and analysis of mitochondrial function.
    Majtan T; Olsen T; Sokolova J; Krijt J; Křížková M; Ida T; Ditrói T; Hansikova H; Vit O; Petrak J; Kuchař L; Kruger WD; Nagy P; Akaike T; Kožich V
    Redox Biol; 2024 Jul; 73():103222. PubMed ID: 38843767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel transgenic mouse model of CBS-deficient homocystinuria does not incur hepatic steatosis or fibrosis and exhibits a hypercoagulative phenotype that is ameliorated by betaine treatment.
    Maclean KN; Sikora J; Kožich V; Jiang H; Greiner LS; Kraus E; Krijt J; Overdier KH; Collard R; Brodsky GL; Meltesen L; Crnic LS; Allen RH; Stabler SP; Elleder M; Rozen R; Patterson D; Kraus JP
    Mol Genet Metab; 2010; 101(2-3):153-62. PubMed ID: 20638879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An orally administered enzyme therapeutic for homocystinuria that suppresses homocysteine by metabolizing methionine in the gastrointestinal tract.
    Skvorak K; Mitchell V; Teadt L; Franklin KA; Lee HO; Kruse N; Huitt-Roehl C; Hang J; Du F; Galanie S; Guan S; Aijaz H; Zhang N; Rajkovic G; Kruger WD; Ismaili MHA; Huisman G; McCluskie K; Silverman AP
    Mol Genet Metab; 2023 Aug; 139(4):107653. PubMed ID: 37463544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzyme replacement with PEGylated cystathionine β-synthase ameliorates homocystinuria in murine model.
    Bublil EM; Majtan T; Park I; Carrillo RS; Hůlková H; Krijt J; Kožich V; Kraus JP
    J Clin Invest; 2016 Jun; 126(6):2372-84. PubMed ID: 27183385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of acute betaine administration on hepatic metabolism of S-amino acids in rats and mice.
    Kim SK; Choi KH; Kim YC
    Biochem Pharmacol; 2003 May; 65(9):1565-74. PubMed ID: 12732369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mice deficient in cystathionine beta synthase display altered homocysteine remethylation pathway.
    Alberto JM; Hamelet J; Noll C; Blaise S; Bronowicki JP; Guéant JL; Delabar JM; Janel N
    Mol Genet Metab; 2007 Aug; 91(4):396-8. PubMed ID: 17562377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.